- Home
- NLSP vs FTFT Comparison
NLSP vs FTFT Comparison
Compare NLSP & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- FTFT
- Stock Information
- Founded
- NLSP 2015
- FTFT N/A
- Country
- NLSP Switzerland
- FTFT United States
- Employees
- NLSP N/A
- FTFT N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- FTFT Business Services
- Sector
- NLSP Health Care
- FTFT Consumer Discretionary
- Exchange
- NLSP Nasdaq
- FTFT Nasdaq
- Market Cap
- NLSP 12.4M
- FTFT 5.9M
- IPO Year
- NLSP 2021
- FTFT N/A
- Fundamental
- Price
- NLSP $2.86
- FTFT $1.15
- Analyst Decision
- NLSP
- FTFT
- Analyst Count
- NLSP 0
- FTFT 0
- Target Price
- NLSP N/A
- FTFT N/A
- AVG Volume (30 Days)
- NLSP 365.2K
- FTFT 46.1K
- Earning Date
- NLSP 07-07-2025
- FTFT 08-18-2025
- Dividend Yield
- NLSP N/A
- FTFT N/A
- EPS Growth
- NLSP N/A
- FTFT N/A
- EPS
- NLSP N/A
- FTFT N/A
- Revenue
- NLSP N/A
- FTFT $2,031,913.00
- Revenue This Year
- NLSP N/A
- FTFT N/A
- Revenue Next Year
- NLSP N/A
- FTFT N/A
- P/E Ratio
- NLSP N/A
- FTFT N/A
- Revenue Growth
- NLSP N/A
- FTFT N/A
- 52 Week Low
- NLSP $1.30
- FTFT $1.01
- 52 Week High
- NLSP $15.59
- FTFT $5.70
- Technical
- Relative Strength Index (RSI)
- NLSP 67.56
- FTFT 39.32
- Support Level
- NLSP $2.19
- FTFT $1.01
- Resistance Level
- NLSP $2.54
- FTFT $1.16
- Average True Range (ATR)
- NLSP 0.19
- FTFT 0.09
- MACD
- NLSP 0.02
- FTFT 0.01
- Stochastic Oscillator
- NLSP 82.76
- FTFT 25.00
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd a clinical-stage biopharmaceutical company focused on the discovery and development of inventive therapies for patients with rare and complex CNS disorders with unmet medical needs. Its compound, mazindol, a triple monoamine reuptake inhibitor and partial orexin receptor 2 agonist, in a proprietary ER formulation, is being developed for the treatment of narcolepsy, IH (follow-on indication), and potentially ADHD (back-up indication). Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.